Related Experiment Videos
Changes in cholesterol levels after coronary artery bypass surgery
O Figueroa1, R Franco-Saenz, P J Mulrow
1Department of Medicine, Medical College of Ohio, Toledo 43699.
Insights
Post-coronary artery bypass surgery (CABG), cholesterol levels significantly drop due to hemodilution. This study found a 77% decrease in cholesterol post-CABG, largely attributed to fluid shifts and blood loss during the procedure.
Area of Science:
- Cardiovascular Surgery
- Clinical Chemistry
Background:
- Cholesterol levels often decrease after coronary artery bypass surgery (CABG).
- The underlying factors contributing to this post-operative cholesterol reduction require investigation.
Purpose of the Study:
- To identify the primary factors responsible for the significant decline in plasma cholesterol levels observed following CABG surgery.
- To compare cholesterol changes in CABG patients with a control group undergoing cholecystectomy.
Main Methods:
- Retrospective analysis of cholesterol levels in 36 CABG patients versus 30 cholecystectomy patients.
- Prospective measurement of lipids and hematocrit in 15 CABG patients at multiple time points during and after surgery.
- Correlation analysis between changes in cholesterol and hematocrit levels.
Main Results:
- CABG patients experienced a 77% decrease in cholesterol within 24 hours, compared to an 18% decrease in cholecystectomy patients.
- Hematocrit levels dropped by 41% in CABG patients versus 6% in the control group.
- A positive correlation (r=0.472) was observed between the fall in cholesterol and the fall in hematocrit in CABG patients.
Conclusions:
- Hemodilution, indicated by a significant drop in hematocrit, is a major contributing factor to the observed decrease in cholesterol levels after CABG.
- The extent of cholesterol reduction is significantly greater after CABG than after cholecystectomy.
- These findings highlight the impact of surgical procedures involving cardiopulmonary bypass on lipid profiles.
Abstract:
To determine the factors responsible for the dramatic fall in cholesterol levels after coronary artery bypass surgery (CABG), the authors reviewed, in a retrospective study, the cholesterol levels of 36 patients who underwent CABG surgery during 1987 and compared their levels with those of a control group of 30 patients who underwent cholecystectomies during the same time. In a prospective study, the authors measured the lipids and the hematocrit levels of 15 patients undergoing CABG surgery before the initiation of cardiopulmonary bypass, after 5 minutes of extracorporeal circulation (ECC), and at the end of ECC. In the CABG group, the plasma cholesterol level fell from 211 +/- 63 mg/dl (mean +/- SE) to 70 +/- 48 mg/dl (p less than 0.01), a 77% decrease within 24 hours of surgery. In the cholecystectomy group, the plasma cholesterol fell from 192.3 +/- 8.9 mg/dl to 158 +/- 76 mg/dl (p less than 0.01), an 18% decrease within 24 hours of surgery. To estimate the contribution of hemodilution or blood loss to the fall in cholesterol, changes in hematocrit were recorded. In the CABG group, hematocrit fell from 39.5 +/- 0.7% to 23.5 +/- 0.7% 24 hours after surgery (41% decrease) (p less than 0.01), whereas in the cholecystectomy group hematocrit fell from 39.4 +/- 0.8% to 37.1 +/- 0.9% on the first postoperative day (6% decrease). There was a positive correlation between the fall in cholesterol and the fall in hematocrit in the CABG group (correlation coefficient 0.472), suggesting that hemodilution was a major factor in the decrease in cholesterol levels.(ABSTRACT TRUNCATED AT 250 WORDS)